246 related articles for article (PubMed ID: 35198466)
21. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease.
Mizukawa Y; Hirahara K; Kano Y; Shiohara T
J Am Acad Dermatol; 2019 Mar; 80(3):670-678.e2. PubMed ID: 30240780
[TBL] [Abstract][Full Text] [Related]
22. DRESS syndrome: A literature review and treatment algorithm.
Calle AM; Aguirre N; Ardila JC; Cardona Villa R
World Allergy Organ J; 2023 Mar; 16(3):100673. PubMed ID: 37082745
[TBL] [Abstract][Full Text] [Related]
23. Co-Occurrence of Multiple Endocrine Abnormalities Induced by the DIHS/DRESS.
Deng M; Wu H; Yu M; Tian Y; Li Y; Xiao X
Int J Endocrinol; 2019; 2019():7959615. PubMed ID: 31687021
[TBL] [Abstract][Full Text] [Related]
24. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.
Stirton H; Shear NH; Dodiuk-Gad RP
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625735
[TBL] [Abstract][Full Text] [Related]
25. Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review.
de Filippis R; Soldevila-MatÃas P; Guinart D; De Fazio P; Rubio JM; Kane JM; Schoretsanitis G
J Psychopharmacol; 2021 Sep; 35(9):1062-1073. PubMed ID: 34044659
[TBL] [Abstract][Full Text] [Related]
26. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
[TBL] [Abstract][Full Text] [Related]
27. Hemodialysis treatment of vancomycin-induced drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome in a patient undergoing peritoneal dialysis.
Mitsuno R; Nakayama T; Uchiyama K; Yoshimoto N; Kusahana E; Morimoto K; Yoshino J; Yoshida T; Kanda T; Yamaguchi S; Hayashi K
CEN Case Rep; 2024 Feb; ():. PubMed ID: 38337109
[TBL] [Abstract][Full Text] [Related]
28. Facial pustules due to drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms may histopathologically mimic eosinophilic pustular folliculitis: A case report.
Ogawa K; Mitsui Y; Miyamoto S; Nakamura-Nishimura Y; Nakanishi Y; Azukizawa H; Asada H
J Cutan Pathol; 2019 May; 46(5):363-367. PubMed ID: 30666704
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y
J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366
[TBL] [Abstract][Full Text] [Related]
30. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
[TBL] [Abstract][Full Text] [Related]
31. Histopathological Characterization of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) and Comparison with Maculopapular Drug Rash (MPDR).
Jindal R; Chugh R; Chauhan P; Shirazi N; Bisht YS
Indian Dermatol Online J; 2022; 13(1):32-39. PubMed ID: 35198465
[TBL] [Abstract][Full Text] [Related]
32. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients.
Ben M'rad M; Leclerc-Mercier S; Blanche P; Franck N; Rozenberg F; Fulla Y; Guesmi M; Rollot F; Dehoux M; Guillevin L; Moachon L
Medicine (Baltimore); 2009 May; 88(3):131-140. PubMed ID: 19440116
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Lee ES; Kiuchi Y; Inomata N; Sueki H
J Dermatol; 2023 Mar; 50(3):387-392. PubMed ID: 36121111
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study.
Jung HY; Park S; Shin B; Lee JH; Lee SJ; Lee MK; Lee WY; Yong SJ; Kim SH
Allergy Asthma Immunol Res; 2019 Jan; 11(1):90-103. PubMed ID: 30479080
[TBL] [Abstract][Full Text] [Related]
35. Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis.
Sasidharanpillai S; Govindan A; Riyaz N; Binitha MP; Muhammed K; Khader A; Reena Mariyath OK; Simin M; Subin K
Indian J Dermatol Venereol Leprol; 2016; 82(1):28-36. PubMed ID: 26728807
[TBL] [Abstract][Full Text] [Related]
36. Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS).
Chi MH; Hui RC; Yang CH; Lin JY; Lin YT; Ho HC; Chung WH; Kuo TT
Br J Dermatol; 2014 Apr; 170(4):866-73. PubMed ID: 24329105
[TBL] [Abstract][Full Text] [Related]
37. DiHS/DRESS syndrome induced by second-line treatment for tuberculosis and Epstein-Barr virus.
Bajoriuniene I; Musteikiene G; Ramonaite A; Sitkauskiene B
Cent Eur J Immunol; 2021; 46(3):401-404. PubMed ID: 34764815
[TBL] [Abstract][Full Text] [Related]
38. DRESS Syndrome.
Jain P; Garg S; Sharma VK; Maheshwari S
J Assoc Physicians India; 2019 Apr; 67(4):87-88. PubMed ID: 31299851
[TBL] [Abstract][Full Text] [Related]
39. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review.
Manieri E; Dondi A; Neri I; Lanari M
Front Med (Lausanne); 2023; 10():1108345. PubMed ID: 37575981
[TBL] [Abstract][Full Text] [Related]
40. Drug Reaction with Eosinophilia and Systemic Symptoms in Children: A Prospective Study.
Sasidharanpillai S; Sabitha S; Riyaz N; Binitha MP; Muhammed K; Riyaz A; Jayakrishnan MP; Reyila VP
Pediatr Dermatol; 2016; 33(2):e162-5. PubMed ID: 27001334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
